No Picture
News

Bloom Science Raises USD $12 Million in Series A Financing

SAN DIEGO: SAN DIEGO, Dec. 9, 2021 /PRNewswire/ — San Diego based biotech company Bloom Science announced today it successfully closed a USD $12 Million Series A financing with a syndicate of life science investors led by Leaps by Bayer, the impact investment arm of Bayer AG, and the ALS… Click here to view original post… […]

No Picture
News

Avidity Biosciences Highlights FSHD Program at Virtual Investor and Analyst Event

LA JOLLA, Calif.: LA JOLLA, Calif., Dec. 9, 2021 /PRNewswire/ — Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced it will be hosting a live webcast investor and analyst day event titled "Volume 3:… Click here to view original post… […]

No Picture
News

Denovo Biopharma and QIAGEN partner to develop companion diagnostic test for the treatment of Diffuse Large B-Cell Lymphoma (DLBCL)

SAN DIEGO and GERMANTOWN, Md. and HILDEN, Germany: SAN DIEGO and GERMANTOWN, Md. and HILDEN, Germany, Dec. 9, 2021 /PRNewswire/ — Denovo Biopharma LLC and QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a collaboration to develop a blood-based companion diagnostic (CDx) test to identify patients expressing Denovo Genomic… Click here to view original post… […]

No Picture
News

Ambrx Biopharma Inc. Presents Positive Data from Ongoing ACE-Breast-01 Phase 1 Clinical Study of ARX788 at San Antonio Breast Cancer Symposium

SAN DIEGO–(BUSINESS WIRE)–Ambrx Biopharma Inc. Presents Positive Data from Ongoing ACE-Breast-01 Phase 1 Clinical Study of ARX788 at San Antonio Breast Cancer Symposium Click here to view original post… […]

No Picture
News

FDA Approves NGS-Based Companion Diagnostic for EGFR Exon20 Insertion Mutant Non-Small Cell Lung Cancer Tumor Tissue

CARLSBAD, Calif.: CARLSBAD, Calif., Dec. 9, 2021 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher Scientific’s Oncomine Dx Target Test as a companion diagnostic (CDx) to help identify non-small cell lung cancer (NSCLC) patients whose tumors carry epidermal growth factor receptor (EGFR)… Click here to view original post… […]

No Picture
News

Heron Therapeutics Announces FDA Approval of a Significant Indication Expansion for ZYNRELEF®

SAN DIEGO: SAN DIEGO, Dec. 9, 2021 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced that the U.S. Food and Drug Administration (FDA) has… Click here to view original post… […]

No Picture
Uncategorized

Global Market Development Manager, Clinical Next-Generation Sequencing – Thermo Fisher Scientific – San Diego, CA

Alternatively, degree in Marketing, Communications or Business, with previous work experience in biotechnology, medical devices, or pharmaceutical industry.From Thermo Fisher Scientific – Thu, 09 Dec 2021 08:14:44 GMT – View all San Diego, CA jobsClick […]

No Picture
Uncategorized

Upstream Research Associate/Scientist (Cell Culture) – Cellics Therapeutics Inc. – San Diego, CA

Cellics Therapeutics is seeking an Upstream Research Associate/Scientist (title dependent on background) to perform cell culture and support various activities…From Indeed – Thu, 09 Dec 2021 00:18:56 GMT – View all San Diego, CA jobsClick […]

No Picture
News

Cymbiotika Launches New Probiotic to Maintain Healthy Gut Function

SAN DIEGO: SAN DIEGO, Dec. 8, 2021 /PRNewswire/ — Cymbiotika, a leading nutritional supplement brand that creates organic, clinically-backed supplements, today announced the addition of Probiotic to its product line. With 19 powerful probiotic strains, trademarked plant-based prebiotics and a unique blend of herbal alchemy and amino acids, Cymbiotika’s Probiotic… Click here to view original post… […]

No Picture
News

Rebus Bio Continues Expansion of Industry-leading Spatial Omics Platform with Breakthrough High-Plex Technology

SANTA CLARA, Calif. & STOCKHOLM–(BUSINESS WIRE)–Rebus Biosystems Inc, (“Rebus Bio”, “Rebus”), an Illumina Ventures-backed life science technology company creating revolutionary tools to advance spatial omics research, today announced that it has acquired the IP and related assay assets of EEL Transcriptomics AB, a privately-held company focused on high-plex spatial transcriptomics… Click here to view original post… […]

No Picture
News

EpicentRx Publishes Proof-of-Concept Research on AdAPT-001

LA JOLLA, Calif.: LA JOLLA, Calif., Dec. 8, 2021 /PRNewswire/ — EpicentRx, Inc., a clinical-stage biotechnology company at the forefront of oncolytic viruses and small molecules for the treatment of cancer and other inflammatory-driven diseases, today announced publication of an original article entitled "Toxicology and biodistribution of AdAPT-001, a replication-competent… Click here to view original post… […]

No Picture
News

Evofem Biosciences to Adjourn Special Meeting of Stockholders on December 8, 2021

SAN DIEGO: SAN DIEGO, Dec. 8, 2021 /PRNewswire/ — Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced that it intends to adjourn, without conducting any business, its 2021 special meeting of stockholders (the "Special Meeting") scheduled to occur at 8:00 a.m. PST on December 8, 2021, and reconvene at 8:00 a.m…. Click here to view original post… […]

No Picture
News

Sorrento Begins Enrollment in Phase 2 Trial of Resiniferatoxin (RTX) for the Treatment of Pain Due to Knee Osteoarthritis (OA)

SAN DIEGO, Dec. 07, 2021 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today announced that the Phase 2 clinical study of RTX for treating knee pain from osteoarthritis (OA) has begun enrollment. This study is a multi-center, double blind, placebo- and active-controlled study to assess the safety… Click here to view original post… […]

No Picture
News

Neurocrine Biosciences Announces Positive Phase 3 Data for KINECT-HD Study Evaluating Valbenazine for Chorea Associated with Huntington Disease

SAN DIEGO: SAN DIEGO, Dec. 7, 2021 /PRNewswire/ — Neurocrine Biosciences (Nasdaq: NBIX) today announced positive top-line data from its Phase 3 KINECT-HD study evaluating the efficacy, safety and tolerability of valbenazine, a selective vesicular monoamine transporter 2 (VMAT2) inhibitor being investigated as a once-daily treatment in adults with chorea… Click here to view original post… […]

No Picture
News

Kintara Therapeutics to Present at the MedInvest Oncology Investor Conference on December 9, 2021

SAN DIEGO: SAN DIEGO, Dec. 7, 2021 /PRNewswire/ — Kintara Therapeutics, Inc. (Nasdaq: KTRA), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that its Chief Executive Officer, Robert E. Hoffman, will present a corporate overview at the MedInvest Oncology Investor Conference, which is… Click here to view original post… […]

No Picture
News

Persephone Biosciences Announces Collaboration with Janssen for Colorectal Arm of ARGONAUT Study

SAN DIEGO: SAN DIEGO, Dec. 7, 2021 /PRNewswire/ — Persephone Biosciences Inc. ("Persephone"), a privately held company investigating the human microbial ecosystem’s effect on therapeutic treatment, diagnostics and disease prevention, today announced a collaboration with Janssen Research & Development, LLC, (Janssen) for the colorectal cancer (CRC) arm of Persephone’s ARGONAUT… Click here to view original post… […]

No Picture
News

Clinical Trials Tech Leader to Launch New Podcast Series Focused on Innovation and Trends in the Biotech, Healthtech, and Data Sectors

SAN DIEGO–(BUSINESS WIRE)–ClinCapture, the industry leader in decentralized clinical trial technology, today announced during the annual Outsourcing in Clinical Trials industry conference a new video podcast series to be sponsored by ClinCapture and hosted by CEO Scott Weidley. TRIALZ with Scott Weidley will provide viewers and listeners with informative and… Click here to view original post… […]

No Picture
News

Richard Lerner, antibody pioneer and longtime president of Scripps Research, dies at 83

Richard Lerner, the esteemed biochemist who pioneered a new way to develop monoclonal antibodies and led Scripps Research Institute to prominence, has passed away. A spokesperson for Scripps told the San Diego Union-Tribune that Lerner died of cancer in his La Jolla home. He was 83… Click here to view original post… […]